Elicio Therapeutics (ELTX) Amortizatization of Intangibles (2020 - 2026)

Elicio Therapeutics (ELTX) reported Amortizatization of Intangibles of $243000.0 for Q1 2026, up 8.0% on a YoY basis from $225000.0 in Q1 2025, and up 2.53% quarter-over-quarter from $237000.0 in Q4 2025.

Elicio Therapeutics (ELTX) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Elicio Therapeutics has reported Amortizatization of Intangibles for 7 years, with the latest figure at $243000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles rose 8.0% year-over-year to $243000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 456.27% YoY), and the FY2025 full-year result was $924000.0, up 1132.0% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $243000.0, up from $237000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $400000.0 in Q3 2025, with the low at -$562000.0 in Q4 2024.
  • Historically, Amortizatization of Intangibles has averaged $160857.1 across 5 years, with a median of $201000.0 in 2022.
  • Annual changes were most pronounced in 2024 — Amortizatization of Intangibles slumped 372.82% — and 2025, when it soared 1438.46%.
  • Elicio Therapeutics' Amortizatization of Intangibles stood at $194000.0 in 2022, then gained by 6.19% to $206000.0 in 2023, then tumbled by 372.82% to -$562000.0 in 2024, then surged by 142.17% to $237000.0 in 2025, then gained by 2.53% to $243000.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $243000.0 (Q1 2026), $237000.0 (Q4 2025), and $400000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Elicio Therapeutics 70.12 Mn 55.17 Mn - 243,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 243,000.00
Mar 31, 2026 243,000.00
Dec 31, 2025 237,000.00
Dec 31, 2025 237,000.00
Sep 30, 2025 400,000.00
Sep 30, 2025 400,000.00
Jun 30, 2025 228,000.00
Jun 30, 2025 228,000.00
Mar 31, 2025 225,000.00
Mar 31, 2025 225,000.00
Dec 31, 2024 -562,000.00
Dec 31, 2024 -562,000.00
Sep 30, 2024 26,000.00
Sep 30, 2024 26,000.00
Dec 31, 2023 206,000.00
Dec 31, 2023 206,000.00
Sep 30, 2023 185,000.00
Sep 30, 2023 185,000.00
Jun 30, 2023 397,000.00
Jun 30, 2023 397,000.00